DiscoverSCI Science PerspectivesScholarly EP023 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings
Scholarly EP023 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings

Scholarly EP023 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings

Update: 2023-11-22
Share

Description

Join us this episode for a conversation with Dr. Michael Fehlings, the most cited neurosurgeon ever on the topic of spinal cord injury (https://doi.org/10.1038/s41393-021-00691-9), for a conversation about the pharmaceutical agent riluzole for the treatment of acute spinal cord injury (SCI). Dr. Fehlings walks us through the past, present, and future of this drug that has proven efficacy in other neurological conditions and that might serve an important role in initial phases of treating SCI. We trust you'll enjoy this conversation about riluzole from the source of a principal investigator physician-scientist studying it from its inauguration in SCI.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Scholarly EP023 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings

Scholarly EP023 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings